{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:24:51Z","timestamp":1792027491962,"version":"4.4.0"},"reference-count":119,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>Therapeutic drug monitoring (TDM) and model\u2010informed precision dosing (MIPD) have evolved as important tools to inform rational dosing of antibiotics in individual patients with infections. In particular, critically ill patients display altered, highly variable pharmacokinetics and often suffer from infections caused by less susceptible bacteria. Consequently, TDM has been used to individualize dosing in this patient group for many years. More recently, there has been increasing research on the use of MIPD software to streamline the TDM process, which can increase the flexibility and precision of dose individualization but also requires adequate model validation and re\u2010evaluation of existing workflows. In parallel, new minimally invasive and noninvasive technologies such as microneedle\u2010based sensors are being developed, which\u2014together with MIPD software\u2014have the potential to revolutionize how patients are dosed with antibiotics. Nonetheless, carefully designed clinical trials to evaluate the benefit of TDM and MIPD approaches are still sparse, but are critically needed to justify the implementation of TDM and MIPD in clinical practice. The present review summarizes the clinical pharmacology of antibiotics, conventional TDM and MIPD approaches, and evidence of the value of TDM\/MIPD for aminoglycosides, beta\u2010lactams, glycopeptides, and linezolid, for which precision dosing approaches have been recommended.<\/jats:p>","DOI":"10.1002\/cpt.2202","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T07:03:54Z","timestamp":1612940634000},"page":"928-941","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":319,"title":["From Therapeutic Drug Monitoring to Model\u2010Informed Precision Dosing for Antibiotics"],"prefix":"10.1111","volume":"109","author":[{"given":"Sebastian G.","family":"Wicha","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy Institute of Pharmacy University of Hamburg Hamburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne\u2010Grete","family":"M\u00e4rtson","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacology University Medical Center Groningen University of Groningen Groningen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet I.","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Uppsala University Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit C.P.","family":"Koch","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena E.","family":"Friberg","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Uppsala University Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan\u2010Willem","family":"Alffenaar","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Sydney Pharmacy School University of Sydney Camperdown Australia"},{"name":"Marie Bashir Institute for Infectious Diseases and Biosecurity University of Sydney Sydney Australia"},{"name":"Westmead Hospital Wentworthville Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris K.","family":"Minichmayr","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Uppsala University Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the International Society of Anti\u2010Infective Pharmacology (ISAP), the PK\/PD study group of the European Society of Clinical Microbiology, Infectious Diseases (EPASG)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,3,16]]},"reference":[{"key":"e_1_2_12_1_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06050-1"},{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.799137"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002473"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2014.07.006"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-1396"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-017-4799-8"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks153"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9070393"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0000000000000810"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2462"},{"key":"e_1_2_12_11_1","unstructured":"International Organization for Standardization (ISO).Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices \u2014 Part 1: Broth micro\u2010dilution reference method for testing thein vitroactivity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases<https:\/\/www.iso.org\/standard\/70464.html>(2006)."},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.111.005769"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx427"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1086\/510079"},{"key":"e_1_2_12_15_1","unstructured":"US Food and Drug Administration.Guidance for industry: exposure\u2010response relationships \u2010 study design data analysis and regulatory applications<https:\/\/www.fda.gov\/regulatory\u2010information\/search\u2010fda\u2010guidance\u2010documents\/exposure\u2010response\u2010relationships\u2010study\u2010design\u2010data\u2010analysis\u2010and\u2010regulatory\u2010applications> (2003)."},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1856-1"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02042-17"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.5.1003"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106059"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw295"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13477"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.582"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2018-0682"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13262"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cotox.2017.03.002"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31826aabc3"},{"key":"e_1_2_12_27_1","unstructured":"European Medicines Agency (EMA).Guideline on bioanalytical method validation. (2012).https:\/\/www.ema.europa.eu\/en\/documents\/scientific\u2010guideline\/guideline\u2010bioanalytical\u2010method\u2010validation_en.pdf"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01433-10"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00951-13"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000643"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01054-12"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000462"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02379-18"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics9040043"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-016-0020-1"},{"key":"e_1_2_12_36_1","doi-asserted-by":"crossref","first-page":"e00483","DOI":"10.1002\/prp2.483","article-title":"In vitro evaluation of an intravenous microdialysis catheter for therapeutic drug monitoring of gentamicin and vancomycin","volume":"7","author":"Mast J.E.","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0643-8"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000390"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2004.02114.x"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14434"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1633"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1650"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12492"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00551"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12353"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-020-00937-4"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.02.029"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00172"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2088"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2065"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.07.005"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01113502"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13901"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-020-02908-7"},{"key":"e_1_2_12_55_1","first-page":"9076","article-title":"Model predictive control with Bayesian updates (MPC) is more robust to model misspecification, compared to standard Bayesian control (sEBE) for Therapeutic Drug Management (TDM). Investigation in a cohort of 315 patients receiving tacrolimus during the fi","volume":"28","author":"Faelens R.","year":"2019","journal-title":"PAGE"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:JOPA.0000029490.76908.0c"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01086153"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.01.017"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0707-9"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-018-0670-4"},{"key":"e_1_2_12_61_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01131-16"},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa320"},{"key":"e_1_2_12_63_1","doi-asserted-by":"crossref","first-page":"e02042","DOI":"10.1128\/AAC.02042-17","article-title":"A prospective trial on the use of trough concentration versus area under the curve (AUC) to determine therapeutic vancomycin dosing","volume":"62","author":"Neely M.N.","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.12.010"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-016-1856-x"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw297"},{"key":"e_1_2_12_67_1","first-page":"e01011","article-title":"Optimization of synergistic combination regimens against carbapenem\u2010 and aminoglycoside\u2010resistant clinical Pseudomonas aeruginosa isolates via mechanism\u2010based pharmacokinetic\/pharmacodynamic modeling","volume":"61","author":"Yadav R.","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_2_12_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.01.017"},{"key":"e_1_2_12_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2104"},{"key":"e_1_2_12_70_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.3.623"},{"key":"e_1_2_12_71_1","first-page":"CD002009","article-title":"Once\u2010daily versus multiple\u2010daily dosing with intravenous aminoglycosides for cystic fibrosis","volume":"9","author":"Bhatt J.","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_12_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/27.suppl_C.41"},{"key":"e_1_2_12_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5955(94)90040-X"},{"key":"e_1_2_12_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1995.tb05719.x"},{"key":"e_1_2_12_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31822c78e9"},{"key":"e_1_2_12_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxaa128"},{"key":"e_1_2_12_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxaa036"},{"key":"e_1_2_12_78_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077169"},{"key":"e_1_2_12_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-019-00551-1"},{"key":"e_1_2_12_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.10.029"},{"key":"e_1_2_12_81_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/pit031"},{"key":"e_1_2_12_82_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318286378e"},{"key":"e_1_2_12_83_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-019-03652-6"},{"key":"e_1_2_12_84_1","first-page":"15","article-title":"Pharmacokinetic\/pharmacodynamic analysis of teicoplanin in patients with MRSA infections","volume":"8","author":"Matsumoto K.","year":"2016","journal-title":"Clin. Pharmacol."},{"key":"e_1_2_12_85_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03272-z"},{"key":"e_1_2_12_86_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31824981a6"},{"key":"e_1_2_12_87_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky314"},{"key":"e_1_2_12_88_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01586-06"},{"key":"e_1_2_12_89_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2378-9"},{"key":"e_1_2_12_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.11.020"},{"key":"e_1_2_12_91_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv123"},{"key":"e_1_2_12_92_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz476"},{"key":"e_1_2_12_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.01.005"},{"key":"e_1_2_12_94_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-4781-x"},{"key":"e_1_2_12_95_1","unstructured":"Zyvox [prescribing information]. (Pfizer NY NY 2020) <https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/021130s039s040 021131s034s035 021132s038s039lbl.pdf> Accessed November 8 2020."},{"key":"e_1_2_12_96_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000710"},{"key":"e_1_2_12_97_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342150-00007"},{"key":"e_1_2_12_98_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00751-17"},{"key":"e_1_2_12_99_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw482"},{"key":"e_1_2_12_100_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01741-15"},{"key":"e_1_2_12_101_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-015-0117-5"},{"key":"e_1_2_12_102_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3181cc6d6f"},{"key":"e_1_2_12_103_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002789"},{"key":"e_1_2_12_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-013-2041-3"},{"key":"e_1_2_12_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2010.02.019"},{"key":"e_1_2_12_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.09.051"},{"key":"e_1_2_12_107_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2016.1166204"},{"key":"e_1_2_12_108_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00605-19"},{"key":"e_1_2_12_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.06.023"},{"key":"e_1_2_12_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.02.044"},{"key":"e_1_2_12_111_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0463-7"},{"key":"e_1_2_12_112_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00177-10"},{"key":"e_1_2_12_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2013.02.020"},{"key":"e_1_2_12_114_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz374"},{"key":"e_1_2_12_115_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00803-2020"},{"key":"e_1_2_12_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.03.008"},{"key":"e_1_2_12_117_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/17.suppl_1.S11"},{"key":"e_1_2_12_118_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piz036"},{"key":"e_1_2_12_119_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2750"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.2202","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cpt.2202","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.2202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T08:29:56Z","timestamp":1699345796000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.2202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,16]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1002\/cpt.2202"],"URL":"https:\/\/doi.org\/10.1002\/cpt.2202","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,16]]},"assertion":[{"value":"2020-12-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}